BridgeBio Pharma (BBIO) FCF Margin (2020 - 2026)
BridgeBio Pharma's FCF Margin was -29.36% in Q2 2026, up 44.15 percentage points from -73.51% a year earlier and up 72.10 percentage points from the prior quarter.
BridgeBio Pharma (BBIO) FCF Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, BridgeBio Pharma's FCF Margin was -61.06% through Jun 30, 2026, up 217.38 percentage points year-over-year; for FY2025, it was -89.03%, up 146.05 percentage points from FY2024.
- FCF Margin shows a five-year change of +4847.71 percentage points (FY2020 to FY2025).
- In earlier years, FCF Margin was -235.09% in FY2024 (+5451.53 pp), -5686.62% in FY2023 (-5140.16 pp), -546.46% in FY2022 (+186.77 pp) and -733.23% in FY2021 (+4203.51 pp).
- The Q2 2026 figure marks the highest quarterly FCF Margin since Q2 2024.
- Compared with a year earlier, FCF Margin has increased for four straight quarters, with an average year-over-year change of +892.60 percentage points over the last eight quarters.
- The best year-over-year quarter for FCF Margin over five years was Q4 2021 (a gain of 79602.72 percentage points); the worst was Q3 2022 (a drop of 34751.88 percentage points).
- Per Business Quant data, BBIO's FCF Margin in the three quarters before Q2 2026 was -101.46% (Q1 2026), -36.62% (Q4 2025) and -91.17% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | BridgeBio Pharma | 13.01 Bn | 10.12 Bn | 228.63 Mn | -29.36% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -29.36% |
| Mar 31, 2026 | -101.46% |
| Dec 31, 2025 | -36.62% |
| Sep 30, 2025 | -91.17% |
| Jun 30, 2025 | -73.51% |
| Mar 31, 2025 | -170.82% |
| Dec 31, 2024 | -3,321.54% |
| Sep 30, 2024 | -6,614.31% |
| Jun 30, 2024 | 3,443.22% |
| Mar 31, 2024 | -104.32% |
| Dec 31, 2023 | -7,177.88% |
| Sep 30, 2023 | -3,560.43% |
| Jun 30, 2023 | -6,933.64% |
| Mar 31, 2023 | -7,904.38% |
| Dec 31, 2022 | -5,029.09% |
| Sep 30, 2022 | -40,213.61% |
| Jun 30, 2022 | -44.55% |
| Mar 31, 2022 | -9,533.29% |
| Dec 31, 2021 | -1,058.75% |
| Sep 30, 2021 | -5,461.73% |
BridgeBio Pharma FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=BBIO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();